Monthly Post 32 – Long road to a Million!!
June 4, 2014
Still we wait. Nothing on the Top Line Data from the Clinical Trial, except the company has said its “in Review” in preparation to be published. How long that review is, well everyone is guessing from now till September.
I have a few reasons to believe its very close. Here is what I see.This past month they moved Ted Myles from acting CEO and CFO to COO and CFO, giving him a pay raise along with
May 1, 2014
The report results of the ACT trials has still not been posted. As we wait and wonder how astounding those results are I will share some great links and some of the happenings these past two months.
First our famous Dr. Lanza was voted as one of the top 100 people in the world. His impact in the Science field is just beginning to be realized and a Nobel Award is in the cards. As ACT’s processes become known, we will go from Health “CARE” to Health “CURE”.
More than two years ago, one of my first claim about the Blastomere is its potential to be the Gold Standard. And, the reasons I thought it would be was because it would be the most primitive of the cells, the least of the cells with programming and functional burden, and the most simple, and direct approach to stem cell replacement as a Therapeutic Approach. Most scientists and doctors would have chosen this approach but for the cultural and religious biases of many countries, doctors, and the
Age of the Cell - A Cure for What Ails the American Healthcare System?
"Sometimes decades go by and nothing happens. Sometimes weeks go by and decades happen."
Vladimir Lenin was most likely discussing changes in social structures and political systems when he wrote this, but the statement may amply apply to the situation now slowly developing, building up like a seemingly dormant volcano, in the American healthcare system. Prices for treatments are rising,
Updated 03-08-2014 at 05:31 AM by sgottenyc
March 1, 2014
Post 30 – Road to a Million,
Well the last post started out with the New England Journal of Medicine was to report results of the ACT trials. Well not sure what the hold up is but so far its not been posted. Till this initial results get posted and published, ACTC stock value will sit pretty much where it is.
So what is going on? Why the silence, why so quiet? A number of presentations have happened, and not much